Person

Marc BOTENGA

European Union · Official source

Records

210 records where Marc BOTENGA is listed as a sponsor, author, or other actor. Search with topics and years

Question· QUESTION_WRITTENE-9-2021-003515answered

Évaluation des déclarations d’absence de conflits d’intérêts

European Union · European Parliament · 12 July 2021

Question· QUESTION_WRITTENE-9-2021-002951answered

The EU and the UN Commission of Inquiry on the Occupied Palestinian Territory and Israel

European Union · European Parliament · 3 June 2021

Question· QUESTION_WRITTENE-9-2021-002848answered

Richiesta agli Stati Uniti di cancellare Cuba dalla lista unilaterale degli Stati sponsor del terrorismo

European Union · European Parliament · 31 May 2021

Question· QUESTION_ORALO-9-2021-000013open

Waiver of patent protection to speed up vaccine production in the EU

European Union · European Parliament · 1 March 2021

Question· QUESTION_ORALO-9-2021-000012open

The backlash against children’s rights due to COVID-19 containment measures

European Union · European Parliament · 1 March 2021

Question· QUESTION_WRITTENE-9-2021-000466answered

The relevance of voluntary pooling and licensing of intellectual property related to COVID-19 therapeutics and vaccines.

European Union · European Parliament · 26 January 2021

Question· QUESTION_WRITTENE-9-2021-000465answered

EU Action Plan on Intellectual Property – compulsory licences

European Union · European Parliament · 26 January 2021

Question· QUESTION_WRITTENE-9-2021-000464answered

India and South Africa’s call for the WTO to suspend or waive intellectual property rights for COVID-19 related technologies

European Union · European Parliament · 26 January 2021

Question· QUESTION_WRITTENE-9-2021-000462answered

Global vaccine shortages and patent sharing according to European Citizens’ Initiative ‘Right to Cure’

European Union · European Parliament · 26 January 2021

Question· QUESTION_WRITTENE-9-2021-000459answered

Suspending intellectual property rights for COVID‑19‑related medicines and technologies

European Union · European Parliament · 26 January 2021

Question· QUESTION_WRITTENE-9-2021-000414answered

The implementation of Directive 93/13/EEC by the Member States

European Union · European Parliament · 25 January 2021

Question· QUESTION_WRITTENE-9-2021-000353answered

Assessment of conflict of interest declarations for members of the team negotiating advance purchase agreements for COVID-19 vaccines

European Union · European Parliament · 20 January 2021

Question· QUESTION_WRITTENE-9-2021-000181answered

COVID‑19 vaccines and transparency

European Union · European Parliament · 13 January 2021

Question· QUESTION_WRITTENE-9-2020-007081answered

Projet européen dans la province de Berkane, commune de Madagh (Maroc)

European Union · European Parliament · 24 December 2020

Question· QUESTION_WRITTENE-9-2020-006864answered

The withholding of Palestinian tax revenues by Israel

European Union · European Parliament · 15 December 2020

Question· QUESTION_WRITTENE-9-2020-006839answered

EU funding and support for research, development and innovation regarding health technologies

European Union · European Parliament · 14 December 2020

Record· QUESTION_WRITTEN_PRIORITYP-9-2020-006641open

Transparency of contracts for COVID-19 vaccines

European Union · European Parliament · 4 December 2020

Question· QUESTION_WRITTENE-9-2020-006592answered

Food safety risks of imported meat from stolen and unidentified horses from Argentina

European Union · European Parliament · 3 December 2020

Question· QUESTION_WRITTENE-9-2020-006200answered

Effets de l’introduction de la productivité comme critère de fixation des salaires minimaux dans la directive européenne

European Union · European Parliament · 15 November 2020

Question· QUESTION_WRITTENE-9-2020-006105answered

Respect, dans les entreprises, des mesures de prévention COVID-19 sur le lieu de travail

European Union · European Parliament · 11 November 2020

Question· QUESTION_WRITTENE-9-2020-006104answered

Mécanismes de fixation de prix du remdesivir dans le cadre des contrats d’achat ou de passation des marchés entre la Commission européenne et Gilead Sciences

European Union · European Parliament · 11 November 2020

Question· QUESTION_WRITTENE-9-2020-006103answered

Renégociation avec Gilead Sciences en considération du résultat des essais cliniques Solidarité de l’OMS

European Union · European Parliament · 11 November 2020

Question· QUESTION_ORALO-9-2020-000067open

Transparency of the advance purchase agreements for COVID-19 vaccines

European Union · European Parliament · 20 October 2020

Record· QUESTION_WRITTEN_PRIORITYP-9-2020-005555open

Renegotiation of the Energy Charter Treaty: alignment with the Paris Agreement before the 2021 COP and next steps envisaged by the EU

European Union · European Parliament · 12 October 2020

Question· QUESTION_WRITTENE-9-2020-005554answered

Energy Charter Treaty renegotiation: the EU’s position regarding fossil fuels protection, the Investor-State Dispute Settlement mechanism and public information

European Union · European Parliament · 12 October 2020

Question· QUESTION_WRITTENE-9-2020-004950answered

Liability for defects in COVID-19 vaccines

European Union · European Parliament · 9 September 2020

Question· QUESTION_WRITTENE-9-2020-004718answered

Composition de l’équipe de négociation des contrats d’achat anticipé d’éventuels vaccins contre la COVID-19

European Union · European Parliament · 31 August 2020

Record· QUESTION_WRITTEN_PRIORITYP-9-2020-004650open